(Affinivax) GlaxoSmithKline has agreed to acquire clinical-stage biopharmaceutical company Affinivax for $3 billion. GSK is expected to pay $2.1 billion upfront and up to $1.2 billion after reaching certain pediatric…
(FT) Unilever has come out to defend the much criticized 50-billion-pound acquisition of GlaxoSmithKline consumer health unit, calling it a “strong strategic fit.” The company says the acquisition will build…
GlaxoSmithKline expects earnings to fall by a mid-to high-single-digit percentage this year due to Covid disruptions and investments in new drug pipelines, according to Reuters. The world’s biggest vaccine maker…